Canada Approves PRADAX (Dabigatran) for Atrial Fibrillation (Afib) Stroke Prevention

StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

On the heels of the US FDA approving dabigatran, the long-awaited alternative to Coumadin (warfarin), comes word that Health Canada has as well. In Canada, dabigatran is known as PRADAX™. Because this is the first alternative to warfarin in Canada, it is big news for the afib community there.

Learn more at:

Health Canada Approves PRADAX as Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation

One Response to Canada Approves PRADAX (Dabigatran) for Atrial Fibrillation (Afib) Stroke Prevention

Leave a Reply to Raye Brownlow Cancel reply

Fields marked with * are required.